A 35-year-old man with a 10-year history of type 2 diabetes mellitus presents with recurrent episodes of severe hypoglycemia despite dietary modifications and reduced insulin doses. His fasting blood glucose is 85 mg/dL, but he experiences symptomatic hypoglycemia (tremor, diaphoresis, confusion) within 2–3 hours of meals. Physical examination reveals a palpable abdominal mass. Which investigation is most appropriate to confirm the suspected diagnosis?

Explanation

## Clinical Scenario Analysis The patient presents with **recurrent hypoglycemia** despite reduced insulin therapy, a palpable abdominal mass, and symptoms occurring 2–3 hours postprandially. This clinical picture is highly suggestive of an **insulinoma** (insulin-secreting neuroendocrine tumor). ## Why Serum Insulin and C-Peptide During Hypoglycemia Is Correct **Key Point:** The hallmark of insulinoma is **inappropriately elevated insulin secretion during documented hypoglycemia** — a pathognomonic finding. ### Whipple's Triad Confirmation 1. Symptoms of hypoglycemia (tremor, diaphoresis, confusion) 2. Documented low blood glucose (< 55 mg/dL) 3. Relief with glucose administration **High-Yield:** In a normal person, hypoglycemia suppresses insulin secretion (insulin < 2 mIU/mL). In insulinoma, insulin remains **detectable or elevated** (typically > 3 mIU/mL) despite concurrent hypoglycemia — this is the **diagnostic gold standard**. ### Role of C-Peptide - **C-peptide > 0.6 ng/mL during hypoglycemia** confirms **endogenous insulin secretion** (not exogenous insulin injection). - Rules out factitious hypoglycemia from surreptitious insulin administration. **Clinical Pearl:** The **insulin-to-glucose ratio** during hypoglycemia is also calculated: $$\text{Insulin-to-Glucose Ratio} = \frac{\text{Serum Insulin (mIU/mL)}}{\text{Blood Glucose (mg/dL) - 30}}$$ A ratio > 0.3 is highly suggestive of insulinoma. ## Investigation Algorithm ```mermaid flowchart TD A[Recurrent hypoglycemia + palpable mass]:::outcome --> B{Whipple's triad present?}:::decision B -->|Yes| C[Measure insulin & C-peptide<br/>during spontaneous hypoglycemia]:::action C --> D{Insulin elevated<br/>+ C-peptide elevated?}:::decision D -->|Yes| E[Insulinoma confirmed]:::outcome D -->|No| F[Consider other causes<br/>e.g., medication, liver disease]:::outcome B -->|No| G[OGTT, HbA1c<br/>not diagnostic]:::action ``` ## Why Other Investigations Are Insufficient | Investigation | Why Not Diagnostic for Insulinoma | |---|---| | **OGTT** | Measures glucose response to oral load; does not assess insulin suppression during hypoglycemia. | | **HbA1c** | Reflects average glycemic control over 3 months; does not diagnose insulinoma. | | **Fasting glucose & lipid profile** | Nonspecific screening tests; do not differentiate insulinoma from other causes of hypoglycemia. | **Tip:** Once insulinoma is biochemically confirmed, **imaging** (CT/MRI abdomen, endoscopic ultrasound) localizes the tumor for surgical planning. [cite:Harrison 21e Ch 415]